Patents by Inventor Peter LETENDRE

Peter LETENDRE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • LOW DOSE CANNABINOID MEDICAMENTS
    Publication number: 20130281523
    Abstract: The present invention provides methods for treating cannabinoid-sensitive disorders with a lose-dose oral cannabinoid which results in delivery of a therapeutic level during an extended clinically-relevant therapeutic window. These methods provide therapeutic dosing while maintaining safe, side effect sparing, levels of a cannabinoid. The present invention also provides methods of determining optimal dosing in treated patients.
    Type: Application
    Filed: November 18, 2011
    Publication date: October 24, 2013
    Inventors: Peter Letendre, David Carley
  • SUSTAINED RELEASE CANNABINOID MEDICAMENTS
    Publication number: 20120231083
    Abstract: The present invention provides a medicament which results in delivery of a therapeutic level of one or more cannabinoids during a clinically relevant therapeutic window. The therapeutic window is a longer window than provided by an immediate release medicament such as Marinol containing an equivalent amount of the cannabinoid. Oral administration of the present compositions provides therapeutic dosing while maintaining safe, side effect sparing, levels of a cannabinoid. The present invention also provides methods of treating cannabinoid-sensitive disorders.
    Type: Application
    Filed: May 17, 2012
    Publication date: September 13, 2012
    Applicants: The Board of Trustees of the University of Illinois, PIER PHARMACEUTICALS
    Inventors: David Carley, Kenton Fedde, John KOLENG, Peter LETENDRE